Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Priyanka Nagar
Institution:
Delhi Pharmaceutical Science and Research University
Observed institution:
Delhi Pharmaceutical Science and Research University
ORCID:
0009-0001-4837-2650
Observed ORCID:
0009-0001-4837-2650
OpenAlex ID:
A5135577112
Comparative preclinical assessment of relugolix tablets and relugolix intravenous injection
2026
·
Priyanka Nagar
, Arvind Kumar Sharma
, et al.
·
Scientific Reports
·
1
PDF
Development and Optimization of a Stable Parenteral Formulation of Relugolix to Overcome Oral Bioavailability Limitations in the Management of Prostate Cancer
2026
·
Priyanka Nagar
, Robin Kumar
, et al.
·
Journal of Pharmaceutical Innovation
Adverse Drug Reactions Associated With Longer All-Oral MDR/XDR-TB Regimens: Prospective Pharmacovigilance Evidence From a High-Burden Tertiary Care Setting in North India
2026
·
Amit Kamboj
, Kshitij Agarwal
, et al.
·
Annals of Pharmacotherapy
Show more works
View as search
Works count:
3
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type